Clinical Trials in Baltimore

Showing 4221-4240 of 20,142 trials

Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students

NCT06633367

This project will first examine nature opportunities, belonging and benefits with a multi-state nature-based intervention with a focus on students of color. In light of the syndemic, 'nature deficit disorder' and poor mental health, the investigators anticipate several far-reaching impacts that will (a) test a nationally useful standardized way to quantify exposure; (b) invest in nature resources and accessibility on campuses; and (c) promote the mental health and therapeutic benefits of nature among young adults. These will lead to understanding the nature exposure and mental health interplay and techniques for quantifying and encouraging nature exposure to treat the on-going youth mental health crisis. Including HBCUs and an hispanic-serving institution is expected to result in heightened visibility of underlying disparities, including structural racism and land-based violence and discrimination, that have contributed to current-day nature gaps and dismantled nature relationships for students of color.

Mental Health

Michigan State University1,545 participantsStarted Sep 2024

Baltimore, Maryland, United States • College Park, Maryland, United States • Salisbury, Maryland, United States +6 more locations

COMPLETEDPhase 1< 1 mile

Post-transplant Flotetuzumab for AML

NCT05506956

The purpose of this research study is to determine if the study drug, flotetuzumab, is safe and tolerable when given to participants with acute myeloid leukemia (AML) that has relapsed after transplant.

Leukemia, Myeloid, Acute

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3 participantsStarted Oct 2022

Baltimore, Maryland, United States

Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students

Post-transplant Flotetuzumab for AML

Find Trials by Condition in Baltimore

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

PKD Clinical and Translational Core Study

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer

Device Feasibility and Acceptability to Improve Insomnia in Cancer

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Effectiveness of Remote Foot Temperature Monitoring

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Use of Dalfampridine in Primary Lateral Sclerosis

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

SPRINT: Signature for Pain Recovery IN Teens

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)